Cinpanemab

• CAT Number: I042236
• CAS Number: 2094516-02-4
• Purity: ≥95%

Cinpanemab（Cat No.:I042236）is an investigational monoclonal antibody designed to target and inhibit the activity of the protein tau, which forms abnormal tangles in the brains of individuals with neurodegenerative diseases like Alzheimer’s disease and progressive supranuclear palsy. By binding to tau, Cinpanemab aims to prevent or reduce the formation of these toxic tau aggregates, potentially slowing disease progression and improving cognitive function. Clinical trials are investigating its safety, efficacy, and ability to modify the course of tau-related neurodegenerative diseases, with the goal of offering a therapeutic approach to these debilitating conditions.